NL-OMON28759尚未招募不适用
A randomized trial of the effect of antiplatelet therapy (Aspirin, Aspirin and Clopidogrel or Ticagrelor) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty.
Antonius Hospital Nieuwegein, Medisch Centrum Alkmaar.0 个研究点目标入组 1,252 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1,252
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients presented for percutaneous endovascular intervention are eligable for inclusion. (1) lesions to the iliac, femoropopliteal and below the knee (BTK) arteries; (2) eligibility of lesions for percutaneous transluminal angioplasty (PTA) or recanalization with or without additional stenting (ST), (3) all TASC lesions [16]; (4) all Rutherford (1-6) classes.
排除标准
- •Exclusion criteria are patients with reported intolerance or hypersensitivity for the study medications, the use of anticoagulant therapy (coumarin derivatives; acenocoumarol / fenprocoumon / warfarin), the use of non-steroidal anti-inflammatory drugs in the two weeks prior to the venapuncture to determine eventual aspirin resistance, a history of platelet/bleeding abnormalities and a platelet count < 100x*10^6/dl.
研究者
相似试验
进行中（未招募）
1 期
The effect of antiplatelet therapy after angioplasty.EUCTR2016-002086-54-NLniversity Medical Center Utrecht1,806
已完成
4 期
A randomized trial of the effect of antiplatelet therapy (Aspirin, Aspirin and Clopidogrel or Ticagrelor) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty.peripheral arterial diseaseNL-OMON47750niversitair Medisch Centrum Utrecht1,806
进行中（未招募）
不适用
A pilot study investigating the antiplatelet effect of generic clopidogrel versus Plavix™ – is there any difference in platelet reactivity in healthy subjects? - The effect of Plavix versus generic clopidogrel on platelet reactivityThe intended indication for the product is for use in all patients with acute coronary syndromes and following coronary artery stentingEUCTR2010-022461-10-GBSouthampton University Hospitals NHS Trust15
招募中
4 期
A randomized clinical trial of an antiplatelet agent in the treatment of acute stroke: cilostazol in the prevention of acute progressing stroke (CAPS) studyCerebral infarctionJPRN-UMIN000001630Tohoku Acute Progressing Stroke Study Group500
已完成
不适用
Study on Therapeutic Effects of Antiplatelet Drugs in Prevention of Occurrence and Inhibition of Progression of Diabetic AtherosclerosisDiabetesJPRN-C000000215DAPC Study Steering Committee400